Sarepta Therapeutics, Inc. (SRPT)
NASDAQ: SRPT · Real-Time Price · USD
18.36
+0.64 (3.61%)
Sep 26, 2025, 4:00 PM EDT - Market closed
Sarepta Therapeutics Analyst Ratings
Total Analysts
31
Consensus Rating
Hold
Price Target
$40.61
Upside
+121.19%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BMO Capital | BMO Capital | Hold → Buy Upgrades $50 | Hold → Buy | Upgrades | $50 | +172.33% | Sep 22, 2025 |
| Guggenheim | Guggenheim | Strong Buy Reiterates $22 | Strong Buy | Reiterates | $22 | +19.83% | Sep 15, 2025 |
| Leerink Partners | Leerink Partners | Hold Maintains $12 → $15 | Hold | Maintains | $12 → $15 | -18.30% | Sep 9, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Sell Reiterates $5 | Strong Sell | Reiterates | $5 | -72.77% | Aug 25, 2025 |
| B of A Securities | B of A Securities | Sell Maintains $17 → $16 | Sell | Maintains | $17 → $16 | -12.85% | Aug 21, 2025 |
| B of A Securities | B of A Securities | Sell Maintains $10 → $17 | Sell | Maintains | $10 → $17 | -7.41% | Aug 20, 2025 |
| Deutsche Bank | Deutsche Bank | Strong Sell Maintains $6 → $12 | Strong Sell | Maintains | $6 → $12 | -34.64% | Aug 15, 2025 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $10 → $19 | Hold | Maintains | $10 → $19 | +3.49% | Aug 7, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $48 → $50 | Buy | Maintains | $48 → $50 | +172.33% | Aug 7, 2025 |
| Barclays | Barclays | Sell → Hold Upgrades $10 → $22 | Sell → Hold | Upgrades | $10 → $22 | +19.83% | Jul 30, 2025 |
| Barclays | Barclays | Sell → Hold Upgrades $10 → $22 | Sell → Hold | Upgrades | $10 → $22 | +19.83% | Jul 29, 2025 |
| Piper Sandler | Piper Sandler | Hold Maintains $11 → $15 | Hold | Maintains | $11 → $15 | -18.30% | Jul 29, 2025 |
| Bernstein | Bernstein | Hold Initiates $13 | Hold | Initiates | $13 | -29.19% | Jul 29, 2025 |
| BMO Capital | BMO Capital | Hold Maintains $25 → $50 | Hold | Maintains | $25 → $50 | +172.33% | Jul 29, 2025 |
| Oppenheimer | Oppenheimer | Hold → Buy Upgrades $30 → $37 | Hold → Buy | Upgrades | $30 → $37 | +101.53% | Jul 29, 2025 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $15 → $20 | Hold | Maintains | $15 → $20 | +8.93% | Jul 29, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.